Publications
Found 2 results
Filters: Author is C.J. Hsieh [Clear All Filters]
“Expression of high-mobility group box protein 1 in diabetic foot atherogenesis”, vol. 14, pp. 4521-4531, 2015.
, “Role of mitochondrial DNA variants and copy number in diabetic atherogenesis”, vol. 11, pp. 3339-3348, 2012.
,
Allen JF and Raven JA (1996). Free-radical-induced mutation vs redox regulation: costs and benefits of genes in organelles. J. Mol. Evol. 42: 482-492.
http://dx.doi.org/10.1007/BF02352278
PMid:8662000
Anderson S, Bankier AT, Barrell BG, de Bruijn MH, et al. (1981). Sequence and organization of the human mitochondrial genome. Nature 290: 457-465.
http://dx.doi.org/10.1038/290457a0
PMid:7219534
Brownlee M (2001). Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820.
http://dx.doi.org/10.1038/414813a
PMid:11742414
Chappey O, Dosquet C, Wautier MP and Wautier JL (1997). Advanced glycation end products, oxidant stress and vascular lesions. Eur. J. Clin. Invest. 27: 97-108.
http://dx.doi.org/10.1046/j.1365-2362.1997.710624.x
PMid:9061302
Croteau DL and Bohr VA (1997). Repair of oxidative damage to nuclear and mitochondrial DNA in mammalian cells. J. Biol. Chem. 272: 25409-25412.
http://dx.doi.org/10.1074/jbc.272.41.25409
PMid:9325246
Du X, Matsumura T, Edelstein D, Rossetti L, et al. (2003). Inhibition of GAPDH activity by poly(ADP-ribose) polymerase activates three major pathways of hyperglycemic damage in endothelial cells. J. Clin. Invest. 112: 1049-1057.
PMid:14523042 PMCid:198524
Gutierrez J, Ballinger SW, Darley-Usmar VM and Landar A (2006). Free radicals, mitochondria, and oxidized lipids: the emerging role in signal transduction in vascular cells. Circ. Res. 99: 924-932.
http://dx.doi.org/10.1161/01.RES.0000248212.86638.e9
PMid:17068300
Lee HC, Yin PH, Lu CY, Chi CW, et al. (2000). Increase of mitochondria and mitochondrial DNA in response to oxidative stress in human cells. Biochem. J. 348: 425-432.
http://dx.doi.org/10.1042/0264-6021:3480425
PMid:10816438 PMCid:1221082
Lee HC, Yin PH, Chi CW and Wei YH (2002). Increase in mitochondrial mass in human fibroblasts under oxidative stress and during replicative cell senescence. J. Biomed. Sci. 9: 517-526.
http://dx.doi.org/10.1007/BF02254978
PMid:12372989
Lu J, Li Z, Zhu Y, Yang A, et al. (2010). Mitochondrial 12S rRNA variants in 1642 Han Chinese pediatric subjects with aminoglycoside-induced and nonsyndromic hearing loss. Mitochondrion 10: 380-390.
http://dx.doi.org/10.1016/j.mito.2010.01.007
PMid:20100600 PMCid:2874659
Madamanchi NR and Runge MS (2007). Mitochondrial dysfunction in atherosclerosis. Circ. Res. 100: 460-473.
http://dx.doi.org/10.1161/01.RES.0000258450.44413.96
PMid:17332437
Mercer JR, Cheng KK, Figg N, Gorenne I, et al. (2010). DNA damage links mitochondrial dysfunction to atherosclerosis and the metabolic syndrome. Circ. Res. 107: 1021-1031.
http://dx.doi.org/10.1161/CIRCRESAHA.110.218966
PMid:20705925 PMCid:2982998
Morino K, Petersen KF, Dufour S, Befroy D, et al. (2005). Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. J. Clin. Invest. 115: 3587-3593.
http://dx.doi.org/10.1172/JCI25151
PMid:16284649 PMCid:1280967
Nishikawa T, Edelstein D, Du XL, Yamagishi S, et al. (2000). Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790.
http://dx.doi.org/10.1038/35008121
PMid:10783895
Petersen KF, Dufour S, Befroy D, Garcia R, et al. (2004). Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N. Engl. J. Med. 350: 664-671.
http://dx.doi.org/10.1056/NEJMoa031314
PMid:14960743 PMCid:2995502
Puddu P, Puddu GM, Galletti L, Cravero E, et al. (2005). Mitochondrial dysfunction as an initiating event in atherogenesis: a plausible hypothesis. Cardiology 103: 137-141.
http://dx.doi.org/10.1159/000083440
PMid:15665536
Rosen P, Nawroth PP, King G, Moller W, et al. (2001). The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab. Res. Rev. 17: 189-212.
http://dx.doi.org/10.1002/dmrr.196
PMid:11424232
Ross R (1993). The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 362: 801-809.
http://dx.doi.org/10.1038/362801a0
PMid:8479518
Sawano T, Tanaka M, Ohno K, Yoneda M, et al. (1996). Mitochondrial DNA mutations associated with the 11778 mutation in Leber's disease. Biochem. Mol. Biol. Int. 38: 693-700.
PMid:8728098
Seneca S, Lissens W, Liebaers I, van den Bergh P, et al. (1998). Pitfalls in the diagnosis of mtDNA mutations. J. Med. Genet. 35: 963-964.
http://dx.doi.org/10.1136/jmg.35.11.963
PMid:9832049 PMCid:1051498
Shtilbans A, El-Schahawi M, Malkin E, Shanske S, et al. (1999). A novel mutation in the mitochondrial DNA transfer ribonucleic acidAsp gene in a child with myoclonic epilepsy and psychomotor regression. J. Child Neurol. 14: 610-613.
http://dx.doi.org/10.1177/088307389901400910
PMid:10488907
Tanaka N, Goto Y, Akanuma J, Kato M, et al. (2010). Mitochondrial DNA variants in a Japanese population of patients with Alzheimer's disease. Mitochondrion 10: 32-37.
http://dx.doi.org/10.1016/j.mito.2009.08.008
PMid:19703591
Tuppen HA, Fattori F, Carrozzo R, Zeviani M, et al. (2008). Further pitfalls in the diagnosis of mtDNA mutations: homoplasmic mt-tRNA mutations. J. Med. Genet. 45: 55-61.
http://dx.doi.org/10.1136/jmg.2007.051185
PMid:18178636
Wong LJ (2007). Pathogenic mitochondrial DNA mutations in protein-coding genes. Muscle Nerve 36: 279-293.
http://dx.doi.org/10.1002/mus.20807
PMid:17503499